Enhabit Q4 2025 Earnings Results & Report

Enhabit EPS Results

• Actual EPS: $0.14
• Consensus EPS: $0.14
• Beat/Miss: Met Expectations
• One Year Ago EPS: N/A
• EPS Beat Rate: 6 of last 8 quarters

Enhabit Revenue Results

• Actual Revenue: $270.40 million
• Expected Revenue: $270.56 million
• Beat/Miss: Missed by -$159.00 thousand
• YoY Revenue Growth: N/A

Enhabit (NYSE:EHAB) (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services. Enhabit’s clinical teams work closely with primary care physicians, hospitals and other care providers to execute tailored care plans, monitor patient progress and adjust treatments as needed. Leveraging proprietary care-management technology, Enhabit aims to streamline clinical workflows, improve care coordination and reduce avoidable hospital readmissions.

Enhabit operates across more than 20 states in both urban and rural markets, having expanded its footprint through a combination of organic growth and strategic acquisitions of regional home health and hospice providers. The company’s leadership team comprises seasoned healthcare executives with decades of experience in home health, hospice and care management. With an emphasis on quality, compliance and patient satisfaction, Enhabit continues to pursue opportunities that strengthen its service capabilities and extend its reach to communities nationwide.